TuHURA Biosciences, Inc. (HURA) — Financial statements
Income statement, balance sheet, and cash flow for TuHURA Biosciences, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 0.00 | 0.00↓100.0% | 0.06↓8.3% | 0.06↑0.0% | 0.06 | |
| Gross Profit | 0.00 | 0.00↑100.0% | -0.06↑8.3% | -0.06↑0.0% | -0.06 | |
| Operating Expenses | ||||||
| R&D Expenses | 21↑54.0% | 13↑400.8% | 3↓71.4% | 9↓38.6% | 15 | |
| General & Administrative Expenses | 8↑75.8% | 4 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 8↑75.8% | 4↓24.7% | 6↑5.7% | 5↓27.2% | 7 | |
| Other Expenses | 4 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 32↑80.2% | 18↑110.2% | 8↓43.0% | 15↓34.9% | 23 | |
| Total Costs & Expenses | 32↑80.2% | 18↑108.8% | 8↓42.9% | 15↓34.8% | 23 | |
| Operating Results | ||||||
| Operating Income | -32↓80.2% | -18↓108.8% | -8↑42.9% | -15↑34.8% | -23 | |
| Depreciation & Amortization | 0.07↓38.9% | 0.12↑112.2% | 0.06↓8.3% | 0.06↑0.0% | 0.06 | |
| EBITDA | -29↓68.4% | -17↓110.9% | -8↑43.9% | -15↑34.9% | -23 | |
| EBIT | -29↓67.7% | -18↓110.9% | -8↑43.8% | -15↑34.8% | -23 | |
| Interest & Other Income | ||||||
| Net Interest Income | -0.49↑87.1% | -4↓5420.4% | 0.07↑23.8% | 0.06↑109.1% | -0.63 | |
| Interest Income | 0.14↓62.3% | 0.36↑303.3% | 0.09↑56.4% | 0.06 | 0.00 | |
| Interest Expense | 0.63↓84.9% | 4↑22044.2% | 0.02 | 0.00↓100.0% | 0.63 | |
| Non-Operating Income | -2↓2146.0% | -0.11↑19.5% | -0.13 | 0.00 | 0.00 | |
| Other Income / Expenses | 2↑143.2% | -4↓3178.5% | 0.13↓10.9% | 0.15↑600.0% | 0.02 | |
| Income Before Tax | -30↓38.6% | -22↓160.6% | -8↑43.2% | -15↑35.4% | -23 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -30↓38.6% | -22↓160.6% | -8↑43.2% | -15↑35.4% | -23 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -30↓38.6% | -22↓160.6% | -8↑43.2% | -15↑35.4% | -23 | |
| Bottom-Line Net Income | -30↓32.7% | -23↓166.4% | -9↑43.4% | -15↑40.2% | -25 | |
| EPS (Basic) | -0.63↑48.1% | -1.21↑89.3% | -11.29↑96.5% | -324.48↑64.1% | -903.04 | |
| EPS (Diluted) | -0.63↑48.1% | -1.21↑89.3% | -11.29↑96.5% | -324.48↑64.1% | -903.04 | |
| Weighted Average Shares | 48↑156.8% | 19↑2378.7% | 0.75↑1526.7% | 0.05↑66.3% | 0.03 | |
| Weighted Average Diluted Shares | 48↑156.8% | 19↑2378.7% | 0.75↑1526.7% | 0.05↑66.3% | 0.03 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.